| Company Name: | Albemarle Corp | | Ticker Symbol: | ALB | | | WWW Address: | www.albemarle.com |
| CEO: | Mr. Luther C. Kissam, IV | | No. of Employees: | 4,304 |
| Common Issue Type: | CS | | Business Description: | Albemarle Corp is a developer, manufacturer and marketer of engineered specialty chemicals. Its operations are managed and reported as three operating segments: Polymer Solutions, Catalysts and Fine Chemistry.
|
| | | Industry Information: | CHEMICALS - Specialty Chemicals [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 66.16 |  -0.27 | - | - | 65.61 | 67.96 | 66.02 | 192905 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,811.8 | 87.8 | 1.61 | 3.47 | 0.80 | 20.7 | 1.4 | 67.96 - 50.88 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 66.43 | $ | | PE Ratio - LTM | 20.7 | |
| Market Capitalisation | 5,811.8 | mil |
| Latest Shares Outstanding | 87.8 | mil |
| Earnings pS (EPS) | 3.47 | $ |
| Dividend pS (DPS) | 0.80 | ¢ |
| Dividend Yield | 1.4 | % |
| Dividend Payout Ratio | 23 | % |
| Revenue per Employee | 637,876 | $ |
| Effective Tax Rate | 20.0 | % |
| Float | 88.1 | mil |
| Float as % of Shares Outstanding | 99.3 | % |
| Foreign Sales | 1,692 | mil |
| Domestic Sales | 1,053 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 14.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 3.00 | % |
| Gross Profit Margin | 35.9 | % |
| EBITDA Margin | 18.3 | % |
| Pre-Tax Profit Margin | 18.0 | % |
| Assets Turnover | 0.8 | % |
| Return on Assets (ROA) | 9.0 | % |
| Return on Equity (ROE) | 17.3 | % |
| Return on Capital Invested (ROCI) | 12.5 | % |
| Current Ratio | 3.2 | |
| Leverage Ratio (Assets/Equity) | 1.9 | |
| Interest Cover | 17.6 | |
| Total Debt/Equity (Gearing Ratio) | 0.39 | |
| LT Debt/Total Capital | 28.0 | % |
| Working Capital pS | 11.03 | $ |
| Cash pS | 4.95 | $ |
| Book-Value pS | 20.47 | $ |
| Tangible Book-Value pS | 16.35 | $ |
| Cash Flow pS | 4.69 | $ |
| Free Cash Flow pS | 1.25 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.25 | |
| Price/Tangible Book Ratio | 4.06 | |
| Price/Cash Flow | 14.2 | |
| Price/Free Cash Flow | 53.1 | |
| P/E as % of Industry Group | 120.0 | % |
| P/E as % of Sector Segment | 123.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 05/06/2013 |
| Dividend Ex-Date | 06/11/2013 |
| Dividend Record Date | 06/13/2013 |
| Dividend Pay Date | 06/30/2013 |
| Dividend Amount | 240 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.96 |
| Current Dividend Yield | 1.4 |
| 5-Y Average Dividend Yield | 1.4 |
| Payout Ratio | 23.0 |
| 5-Y Average Payout Ratio | 20.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -1.4 | 99 | 6,354 | 17,625 |
| 4 Weeks | 67.96 | 58.74 | 58.86 | 12.9 | 108 | 6,671 | 120,075 |
| 13 Weeks | 67.96 | 56.64 | 65.00 | 2.2 | 94 | 7,379 | 457,476 |
| 26 Weeks | 67.96 | 56.03 | 57.54 | 15.5 | 98 | 7,040 | 865,961 |
| 52 Weeks | 67.96 | 50.88 | 61.43 | 8.1 | 86 | 8,087 | 1,997,480 |
| YTD | 67.96 | 56.64 | - | 6.9 | 92 | 7,282 | 713,684 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 66.66 | 65.55 | 61.92 | 61.59 | 59.77 | 1.61 | 1.71 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 3.74 | 31.0 | 8.35 |
| Income | 13.62 | 50.1 | 9.71 |
| Dividend | 13.17 | 96.6 | 15.50 |
| Capital Spending | 12.68 | NA | 38.44 |
| R&D | 4.68 | NA | 10.35 |
| Normalized Inc. | 13.90 | NA | 15.09 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -9.8 | -9.8 | -4.3 |
| Earnings % | -17.1 | -17.1 | -24.3 |
| EPS % | -21.7 | -21.7 | -27.3 |
| EPS $ | -0.26 | -0.26 | -1.30 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 29.74 |
| Current Ratio | 3.7 |
| Quick Ratio (Acid Test) | 2.3 |
| Liquidity Ratio (Cash) | 1.24 |
| Receivables Turnover | 6.7 |
| Average Collection Period | 54 |
| Working Capital/Equity | 55.8 |
| Working Capital pS | 11.50 |
| Cash-Flow pS | 4.83 |
| Free Cash-Flow pS | 1.55 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.93 |
| Financial Leverage Ratio (Assets/Equity) | 1.9 |
| Debt Ratio | 46.7 |
| Total Debt/Equity (Gearing Ratio) | 0.38 |
| LT Debt/Equity | 0.37 |
| LT Debt/Capital Invested | 48.4 |
| LT Debt/Total Liabilities | 42.8 |
| Interest Cover | 13.6 |
| Interest/Capital Invested | 1.07 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 6.74 |
| Tobin's Q Ratio | 1.70 |
| Current P/E Ratio - LTM | 20.70 |
| Enterprise Value (EV)/EBITDA | 11.29 |
| Enterprise Value (EV)/Free Cash Flow | 58.96 |
| Dividend Yield | 1.4 |
| Price/Tangible Book Ratio - LTM | 4.06 |
| Price/Book Ratio - LTM | 3.25 |
| Price/Cash Flow Ratio | 14.2 |
| Price/Free Cash Flow Ratio - LTM | 53.1 |
| Price/Sales Ratio | 2.18 |
| P/E Ratio (1 month ago) - LTM | 18.4 |
| P/E Ratio (26 weeks ago) - LTM | 15.0 |
| P/E Ratio (52 weeks ago) - LTM | 12.7 |
| 5-Y High P/E Ratio | 21.9 |
| 5-Y Low P/E Ratio | 7.7 |
| 5-Y Average P/E Ratio | 14.8 |
| Current P/E Ratio as % of 5-Y Average P/E | 140 |
| P/E as % of Industry Group | 120.0 |
| P/E as % of Sector Segment | 123.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 19.6 |
| PER SHARE FIGURES |
| LT Debt pS | 7.72 |
| Current Liabilities pS | 4.33 |
| Tangible Book Value pS - LTM | 16.35 |
| Book Value pS - LTM | 20.47 |
| Capital Invested pS | 28.69 |
| Cash pS - LTM | 4.95 |
| Cash Flow pS - LTM | 4.69 |
| Free Cash Flow pS - LTM | 1.25 |
| Earnings pS (EPS) | 3.47 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.01 |
| Free Cash Flow Margin 5YEAR AVG | 6.77 |
| Net Profit Margin | 12.0 |
| Net Profit Margin - 5YEAR AVRG. | 11.7 |
| Equity Productivity | 1.50 |
| Return on Equity (ROE) | 18.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 20.6 |
| Capital Invested Productivity | 1.09 |
| Return on Capital Invested (ROCI) | 13.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 13.2 |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | 9.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | 9.5 |
| Gross Profit Margin | 35.9 |
| Gross Profit Margin - 5YEAR AVRG. | 34.0 |
| EBITDA Margin - LTM | 18.3 |
| EBIT Margin - LTM | 19.1 |
| Pre-Tax Profit Margin | 15.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 12.6 |
| Effective Tax Rate | 20.0 |
| Effective Tax Rate - 5YEAR AVRG. | -0.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 144 |
| Revenue per Employee | 637,876 |
| Net Income per Employee | 76,702 |
| Average Collection Period | 55 |
| Receivables Turnover | 6.7 |
| Day's Inventory Turnover Ratio | 89 |
| Inventory Turnover | 4.0 |
| Inventory/Sales | 15.6 |
| Accounts Payble/Sales | 6.30 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 2.69 |
| Fixed Assets Turnover | 1.35 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 5.75 |
| Revenue per $ Plant | 2.12 |
| Revenue per $ Common Equity | 1.50 |
| Revenue per $ Capital Invested | 1.09 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 10.9 |
| Research & Devlopment (R&D) as % of Revenue | 2.9 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 2.9 |
|
|  
|
| |
 |  |
